FDA
-
-
-
-
-
-
-
Prelude Therapeutics gets FDA clearance for JAK2 inhibitor trial
-
-
-
-
-
-
-
Prelude Therapeutics (PRLD) Granted FDA Clearance of IND for PRT3789
-
-
-
-
-
-
-
Prelude Therapeutics Announces First Quarter 2021 Financial Results and Operations Update
-
330,721 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

